Literature DB >> 16137822

Intermittent catheterisation with hydrophilic-coated catheters (SpeediCath) reduces the risk of clinical urinary tract infection in spinal cord injured patients: a prospective randomised parallel comparative trial.

D J M K De Ridder1, K Everaert, L García Fernández, J V Forner Valero, A Borau Durán, M L Jauregui Abrisqueta, M G Ventura, A Rodriguez Sotillo.   

Abstract

OBJECTIVES: To compare the performance of SpeediCath hydrophilic-coated catheters versus uncoated polyvinyl chloride (PVC) catheters, in traumatic spinal cord injured patients presenting with functional neurogenic bladder-sphincter disorders.
METHODS: A 1-year, prospective, open, parallel, comparative, randomised, multi centre study included 123 male patients, > or =16 y and injured within the last 6 months. Primary endpoints were occurrence of symptomatic urinary tract infection (UTI) and hematuria. Secondary endpoints were development of urethral strictures and convenience of use. The main hypothesis was that coated catheters cause fewer complications in terms of symptomatic UTIs and hematuria.
RESULTS: 57 out of 123 patients completed the 12-month study. Fewer patients using the SpeediCath hydrophilic-coated catheter (64%) experienced 1 or more UTIs compared to the uncoated PVC catheter group (82%) (p = 0.02). Thus, twice as many patients in the SpeediCath group were free of UTI. There was no significant difference in the number of patients experiencing bleeding episodes (38/55 SpeediCath; 32/59 PVC) and no overall difference in the occurrence of hematuria, leukocyturia and bacteriuria.
CONCLUSIONS: The results indicate that there is a beneficial effect regarding UTI when using hydrophilic-coated catheters.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16137822     DOI: 10.1016/j.eururo.2005.07.018

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  44 in total

1.  [100 years urology in Germany. Neuro-urology].

Authors:  J Pannek; P M Braun; W Diederichs; M Hohenfellner; K P Jünemann; H Madersbacher; A Reitz; S Schumacher; M Stöhrer
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

Review 2.  [Single-use intermittent catheterisation].

Authors:  U Grigoleit; J Pannek; M Stöhrer
Journal:  Urologe A       Date:  2006-02       Impact factor: 0.639

3.  Validity, accuracy, and predictive value of urinary tract infection signs and symptoms in individuals with spinal cord injury on intermittent catheterization.

Authors:  Luiz M Massa; Jeanne M Hoffman; Diana D Cardenas
Journal:  J Spinal Cord Med       Date:  2009       Impact factor: 1.985

Review 4.  Prevention of urinary tract infections in patients with spinal cord injury.

Authors:  Ahmad Salameh; Mayar Al Mohajer; Rabih O Daroucihe
Journal:  CMAJ       Date:  2015-06-15       Impact factor: 8.262

5.  [S2k guidelines of the German Society of Urology. Management and implementation of intermittent catheterization in neurogenic bladder dysfunction].

Authors:  I Kurze; V Geng; R Böthig
Journal:  Urologe A       Date:  2015-03       Impact factor: 0.639

Review 6.  Infections in the spinal cord-injured population: a systematic review.

Authors:  L Y Garcia-Arguello; J C O'Horo; A Farrell; R Blakney; M R Sohail; C T Evans; N Safdar
Journal:  Spinal Cord       Date:  2016-12-06       Impact factor: 2.772

Review 7.  [The relevance of catheterization in neurourology].

Authors:  R Böthig; H Burgdörfer
Journal:  Urologe A       Date:  2012-02       Impact factor: 0.639

Review 8.  Medical Management of Neurogenic Bladder for Children and Adults: A Review.

Authors:  Elizabeth Lucas
Journal:  Top Spinal Cord Inj Rehabil       Date:  2019

9.  Hydrophilic catheters: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-03-01

10.  Best practices for the treatment and prevention of urinary tract infection in the spinal cord injured population: The Alberta context.

Authors:  Timothy C Hill; Richard Baverstock; Kevin V Carlson; Eric P Estey; Gary J Gray; Denise C Hill; Chester Ho; Rosemary H McGinnis; Katherine Moore; Raj Parmar
Journal:  Can Urol Assoc J       Date:  2013 Mar-Apr       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.